Victory Capital Management
HCAT icon

Victory Capital Management’s Health Catalyst HCAT Stock Holding History

Victory Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-871,135
Closed -$12.6M – 2725
2022
Q2 		$12.6M Sell
871,135
-127,708
-13% -$2.18M 0.01% 987
2022
Q1 		$26.1M Buy
998,843
+174,954
+21% +$4.96M 0.03% 784
2021
Q4 		$32.6M Sell
823,889
-393,836
-32% -$17.9M 0.03% 729
2021
Q3 		$60.9M Buy
1,217,725
+340,087
+39% +$18.5M 0.06% 458
2021
Q2 		$48.7M Buy
877,638
+37,604
+4% +$2M 0.05% 576
2021
Q1 		$39.3M Sell
840,034
-306,324
-27% -$14.8M 0.04% 642
2020
Q4 		$49.9M Sell
1,146,358
-40,163
-3% -$1.48M 0.06% 525
2020
Q3 		$43.4M Buy
1,186,521
+94,799
+9% +$3.22M 0.06% 509
2020
Q2 		$31.8M Sell
1,091,722
-1,032,156
-49% -$28.5M 0.04% 591
2020
Q1 		$55.5M Buy
2,123,878
+1,274,772
+150% +$38.9M 0.05% 534
2019
Q4 		$29.5M Buy
849,106
+14,853
+2% +$492K 0.04% 692
2019
Q3 		$26.4M Buy
+834,253
New +$32.8M 0.03% 695

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Victory Capital Management's HCAT Position: Q3 2022 in Review

Victory Capital Management sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 871,135 shares — an estimated $12.6M sold.

Victory Capital Management first reported a position in HCAT in Q3 2019 and held it in 12 quarters. The position peaked at $60.9M in Q3 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • Victory Capital Management reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 871,135 Health Catalyst shares in Q3 2022, an estimated $12.6M.
  • Victory Capital Management first reported a position in Health Catalyst in Q3 2019 and held it in 12 quarters.
  • Victory Capital Management's Health Catalyst position peaked at $60.9M in Q3 2021.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.